Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Stereotactic Body Radiation Therapy × anlotinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Thyroid Neoplasms 2 Esophageal Neoplasms 2 Stereotactic Body Radiation Therapy 1 Lung Neoplasms 1 Liver Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

anlotinib 1 Angiogenesis Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04912128 2021-06-03

AnloSBRT

Peking University Third Hospital

Stereotactic Body Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡